[HTML][HTML] Knock down of TIMP-2 by siRNA and CRISPR/Cas9 mediates diverse cellular reprogramming of metastasis and chemosensitivity in ovarian cancer

RM Escalona, S Chu, E Kadife, JK Kelly… - Cancer Cell …, 2022 - Springer
Background The endogenous tissue inhibitor of metalloproteinase-2 (TIMP-2), through its
homeostatic action on certain metalloproteinases, plays a vital role in remodelling …

[PDF][PDF] Knock down of TIMP-2 by siRNA and CRISPR/Cas9 mediates diverse cellular reprogramming of metastasis and chemosensitivity in ovarian cancer

RM Escalona, S Chu, E Kadife, JK Kelly… - 2022 - academia.edu
Background: The endogenous tissue inhibitor of metalloproteinase-2 (TIMP-2), through its
homeostatic action on certain metalloproteinases, plays a vital role in remodelling …

Knock down of TIMP-2 by siRNA and CRISPR/Cas9 mediates diverse cellular reprogramming of metastasis and chemosensitivity in ovarian cancer.

RM Escalona, S Chu, E Kadife, JK Kelly… - Cancer Cell …, 2022 - go.gale.com
Background The endogenous tissue inhibitor of metalloproteinase-2 (TIMP-2), through its
homeostatic action on certain metalloproteinases, plays a vital role in remodelling …

Knock down of TIMP-2 by siRNA and CRISPR/Cas9 mediates diverse cellular reprogramming of metastasis and chemosensitivity in ovarian cancer.

RM Escalona, S Chu, E Kadife, JK Kelly… - Cancer Cell …, 2022 - search.ebscohost.com
Background: The endogenous tissue inhibitor of metalloproteinase-2 (TIMP-2), through its
homeostatic action on certain metalloproteinases, plays a vital role in remodelling …

Knock down of TIMP-2 by siRNA and CRISPR/Cas9 mediates diverse cellular reprogramming of metastasis and chemosensitivity in ovarian cancer

RM Escalona, S Chu, E Kadife… - Cancer cell …, 2022 - pubmed.ncbi.nlm.nih.gov
Background The endogenous tissue inhibitor of metalloproteinase-2 (TIMP-2), through its
homeostatic action on certain metalloproteinases, plays a vital role in remodelling …

[HTML][HTML] Knock down of TIMP-2 by siRNA and CRISPR/Cas9 mediates diverse cellular reprogramming of metastasis and chemosensitivity in ovarian cancer

RM Escalona, S Chu, E Kadife, JK Kelly… - Cancer Cell …, 2022 - ncbi.nlm.nih.gov
Background The endogenous tissue inhibitor of metalloproteinase-2 (TIMP-2), through its
homeostatic action on certain metalloproteinases, plays a vital role in remodelling …

[HTML][HTML] Knock down of TIMP-2 by siRNA and CRISPR/Cas9 mediates diverse cellular reprogramming of metastasis and chemosensitivity in ovarian cancer

RM Escalona, S Chu, E Kadife… - Cancer Cell …, 2022 - cancerci.biomedcentral.com
The endogenous tissue inhibitor of metalloproteinase-2 (TIMP-2), through its homeostatic
action on certain metalloproteinases, plays a vital role in remodelling extracellular matrix …

Knock down of TIMP-2 by siRNA and CRISPR/Cas9 mediates diverse cellular reprogramming of metastasis and chemosensitivity in ovarian cancer

R Escalona, S Chu, E Kadife, J Kelly… - Cancer Cell …, 2022 - europepmc.org
Background The endogenous tissue inhibitor of metalloproteinase-2 (TIMP-2), through its
homeostatic action on certain metalloproteinases, plays a vital role in remodelling …

Knock down of TIMP-2 by siRNA and CRISPR/Cas9 mediates diverse cellular reprogramming of metastasis and chemosensitivity in ovarian cancer.

RM Escalona, S Chu, E Kadife, JK Kelly… - Cancer Cell …, 2022 - europepmc.org
Background The endogenous tissue inhibitor of metalloproteinase-2 (TIMP-2), through its
homeostatic action on certain metalloproteinases, plays a vital role in remodelling …

[PDF][PDF] Knock down of TIMP-2 by siRNA and CRISPR/Cas9 mediates diverse cellular reprogramming of metastasis and chemosensitivity in ovarian cancer

RM Escalona, S Chu, E Kadife, JK Kelly… - 2022 - cancerci.biomedcentral.com
Background: The endogenous tissue inhibitor of metalloproteinase-2 (TIMP-2), through its
homeostatic action on certain metalloproteinases, plays a vital role in remodelling …